Effect of the Consumption of Alcohol-free Beers With Different Carbohydrates Composition on Postprandial Metabolic Response

September 29, 2021 updated by: Rocio Mateo-Gallego, Universidad de Zaragoza
The overall objective of this study is to explore the glycemic index and glycemic load induced by an alcohol-free beer with modified composition (including almost full fermentation of carbohydrates and the addition of isomaltulose and a resistant maltodextrin), as well as its postprandial metabolic response, compared to the effect induced by: a) an alcohol-free beer with a usual composition; b) an alcohol-free beer with modified composition (including almost full fermentation of carbohydrates and the addition of a resistant maltodextrin). This study includes two cross-over sub-studies recruiting healthy participants. In the first one, 10 healthy volunteers receive 25 g of carbohydrates coming from: regular alcohol-free beer (RB), alcohol-free beer with almost completely eliminated maltose and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB), alcohol-free beer with the same maltose removal enriched with resistant maltodextrin (2.0 g/100 mL) (MB) and glucose solution. In the second study, 20 healthy volunteers are provided with 50 g of carbohydrates from white bread and water and the same meal plus 14.3 g of carbohydrates coming from: RB, IMB, MB and extra white bread. Blood is sampled at baseline and for 2 h, every 15 min, after ingestion.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zaragoza, Spain, 50009
        • Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Universidad de Zaragoza

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI between 18.5 and 27.5 kg/m2.

Exclusion Criteria:

  • Presence of cardiometabolic pathology such as dyslipemia (total cholesterol > 200 mg/dL and/or triglycerides > 150 mg/dL, and/or taking lipid-lowering drugs), prediabetes or type 1 or 2 diabetes mellitus (glucose ≥ 100 mg/dL and/or glycosylated hemoglobin ≥ 5.7% and/or taking hypoglycemic drugs) or high blood pressure without drug treatment.
  • Presence of other chronic pathologies that could interfere with the results of the study such as cardiovascular disease, kidney disease, thyroid disease or liver disease.
  • Presence of intestinal malabsorption syndromes and/or presence of Chron disease or ulcerative colitis.
  • Use of drugs that may interfere with lipid and/or glycidic metabolism.
  • Presence of some analytical alteration that could interfere with the results of the study.
  • Increased or decreased body weight of ≥ 5 kg in the last 6 months.
  • Gluten intolerance.
  • Regular intake of functional foods such as phytosterols or red rice yeast, which have a significant effect on lipid or glycidic metabolism, in the last 6 weeks.
  • Intake of vitamin supplements.
  • Hormone replacement therapy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: First sub-study: Glucose beverage
This intervention entails the intake of a beverage including 25 g of glucose.
Subjects were provided with: a) Glucose beverage; b) Regular alcohol-free beer; c) Alcohol-free beer with modified composition (isomaltulose + maltodextrin); d) Alcohol-free beer with modified composition (++ maltodextrin).
Experimental: First sub-study: Regular alcohol-free beer
This intervention entails the intake of regular alcohol-free beer including 25 of carbohydrates.
Subjects were provided with: a) Glucose beverage; b) Regular alcohol-free beer; c) Alcohol-free beer with modified composition (isomaltulose + maltodextrin); d) Alcohol-free beer with modified composition (++ maltodextrin).
Experimental: First sub-study: Alcohol-free beer with modified composition (isomaltulose + maltodextrin)
This intervention entails the intake of an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB). This beverage included 25 g of carbohydrates.
Subjects were provided with: a) Glucose beverage; b) Regular alcohol-free beer; c) Alcohol-free beer with modified composition (isomaltulose + maltodextrin); d) Alcohol-free beer with modified composition (++ maltodextrin).
Experimental: First sub-study: Alcohol-free beer with modified composition (++ maltodextrin)
This intervention entails the intake of an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with a resistant maltodextrin (2.0 g/100 mL) (MB). This beverage included 25 g of carbohydrates.
Subjects were provided with: a) Glucose beverage; b) Regular alcohol-free beer; c) Alcohol-free beer with modified composition (isomaltulose + maltodextrin); d) Alcohol-free beer with modified composition (++ maltodextrin).
Active Comparator: Second sub-study: White bread + Water
This intervention entails the intake of white bread (providing 50 g of carbohydrates) and water.
Subjects were provided with: a) White bread + Water; b) White bread + Regular alcohol-free beer; c) White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin); d) White bread + Alcohol-free beer enriched with ++ maltodextrin; e) Extra-White bread + Water.
Experimental: Second sub-study: White bread + Regular alcohol-free beer
This intervention entails the intake of white bread (providing 50 g of carbohydrates) and regular alcohol-free beer (providing 14.3 g of carbohydrates).
Subjects were provided with: a) White bread + Water; b) White bread + Regular alcohol-free beer; c) White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin); d) White bread + Alcohol-free beer enriched with ++ maltodextrin; e) Extra-White bread + Water.
Experimental: Second sub-study: White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin)
This intervention entails the intake of white bread (providing 50 g of carbohydrates) and an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB). This beverage included 14.3 g of carbohydrates.
Subjects were provided with: a) White bread + Water; b) White bread + Regular alcohol-free beer; c) White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin); d) White bread + Alcohol-free beer enriched with ++ maltodextrin; e) Extra-White bread + Water.
Experimental: Second sub-study: White bread + Alcohol-free beer enriched with ++ maltodextrin
This intervention entails the intake of white bread (providing 50 g of carbohydrates) and an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched a resistant maltodextrin (2.0 g/100 mL) (MB). This beverage included 14.3 g of carbohydrates.
Subjects were provided with: a) White bread + Water; b) White bread + Regular alcohol-free beer; c) White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin); d) White bread + Alcohol-free beer enriched with ++ maltodextrin; e) Extra-White bread + Water.
Active Comparator: Second sub-study: Extra-White bread + Water
This intervention entails the intake of white bread which provides 64.3 g (50 g + 14.3 g) of carbohydrates and water. This intervention would be the comparator in carbohydrates-equally conditions.
Subjects were provided with: a) White bread + Water; b) White bread + Regular alcohol-free beer; c) White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin); d) White bread + Alcohol-free beer enriched with ++ maltodextrin; e) Extra-White bread + Water.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Glucose
Time Frame: Change from Baseline to 15-minutes after consumption of the beverage.
Change from Baseline to 15-minutes after consumption of the beverage.
Glucose
Time Frame: Change from Baseline to 30-minutes after consumption of the beverage.
Change from Baseline to 30-minutes after consumption of the beverage.
Glucose
Time Frame: Change from Baseline to 45-minutes after consumption of the beverage.
Change from Baseline to 45-minutes after consumption of the beverage.
Glucose
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
Glucose
Time Frame: Change from Baseline to 75-minutes after consumption of the beverage.
Change from Baseline to 75-minutes after consumption of the beverage.
Glucose
Time Frame: Change from Baseline to 90-minutes after consumption of the beverage.
Change from Baseline to 90-minutes after consumption of the beverage.
Glucose
Time Frame: Change from Baseline to 105-minutes after consumption of the beverage.
Change from Baseline to 105-minutes after consumption of the beverage.
Glucose
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.
Insulin
Time Frame: Change from Baseline to 15-minutes after consumption of the beverage.
Change from Baseline to 15-minutes after consumption of the beverage.
Insulin
Time Frame: Change from Baseline to 30-minutes after consumption of the beverage.
Change from Baseline to 30-minutes after consumption of the beverage.
Insulin
Time Frame: Change from Baseline to 45-minutes after consumption of the beverage.
Change from Baseline to 45-minutes after consumption of the beverage.
Insulin
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
Insulin
Time Frame: Change from Baseline to 75-minutes after consumption of the beverage.
Change from Baseline to 75-minutes after consumption of the beverage.
Insulin
Time Frame: Change from Baseline to 90-minutes after consumption of the beverage.
Change from Baseline to 90-minutes after consumption of the beverage.
Insulin
Time Frame: Change from Baseline to 105-minutes after consumption of the beverage.
Change from Baseline to 105-minutes after consumption of the beverage.
Insulin
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.
GLP-1
Time Frame: Change from Baseline to 15-minutes after consumption of the beverage.
Change from Baseline to 15-minutes after consumption of the beverage.
GLP-1
Time Frame: Change from Baseline to 30-minutes after consumption of the beverage.
Change from Baseline to 30-minutes after consumption of the beverage.
GLP-1
Time Frame: Change from Baseline to 45-minutes after consumption of the beverage.
Change from Baseline to 45-minutes after consumption of the beverage.
GLP-1
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
GLP-1
Time Frame: Change from Baseline to 75-minutes after consumption of the beverage.
Change from Baseline to 75-minutes after consumption of the beverage.
GLP-1
Time Frame: Change from Baseline to 90-minutes after consumption of the beverage.
Change from Baseline to 90-minutes after consumption of the beverage.
GLP-1
Time Frame: Change from Baseline to 105-minutes after consumption of the beverage.
Change from Baseline to 105-minutes after consumption of the beverage.
GLP-1
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.
GIP
Time Frame: Change from Baseline to 15-minutes after consumption of the beverage.
Change from Baseline to 15-minutes after consumption of the beverage.
GIP
Time Frame: Change from Baseline to 30-minutes after consumption of the beverage.
Change from Baseline to 30-minutes after consumption of the beverage.
GIP
Time Frame: Change from Baseline to 45-minutes after consumption of the beverage.
Change from Baseline to 45-minutes after consumption of the beverage.
GIP
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
GIP
Time Frame: Change from Baseline to 75-minutes after consumption of the beverage.
Change from Baseline to 75-minutes after consumption of the beverage.
GIP
Time Frame: Change from Baseline to 90-minutes after consumption of the beverage.
Change from Baseline to 90-minutes after consumption of the beverage.
GIP
Time Frame: Change from Baseline to 105-minutes after consumption of the beverage.
Change from Baseline to 105-minutes after consumption of the beverage.
GIP
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.

Secondary Outcome Measures

Outcome Measure
Time Frame
Leptin
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
Leptin
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.
Glucagon
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
Glucagon
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.
Ghrelin
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
Ghrelin
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.
Polypeptide Y
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
Polypeptide Y
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.
Pancreatic polypeptide
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
Pancreatic polypeptide
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.
HDL cholesterol
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
HDL cholesterol
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.
LDL cholesterol
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
LDL cholesterol
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.
Triglycerides
Time Frame: Change from Baseline to 60-minutes after consumption of the beverage.
Change from Baseline to 60-minutes after consumption of the beverage.
Triglycerides
Time Frame: Change from Baseline to 120-minutes after consumption of the beverage.
Change from Baseline to 120-minutes after consumption of the beverage.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

December 31, 2020

Study Completion (Actual)

March 30, 2021

Study Registration Dates

First Submitted

March 2, 2021

First Submitted That Met QC Criteria

March 5, 2021

First Posted (Actual)

March 10, 2021

Study Record Updates

Last Update Posted (Actual)

September 30, 2021

Last Update Submitted That Met QC Criteria

September 29, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • PI19/477

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Diet

Clinical Trials on Sub-study 1

3
Subscribe